# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061553
Filing Date
2023-11-09
Accepted
2023-11-09 08:02:36
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acrv-20230930.htm iXBRL | 10-Q | 2767269
2 | EX-31.1 | acrv-ex31_1.htm | EX-31.1 | 17044
3 | EX-31.2 | acrv-ex31_2.htm | EX-31.2 | 17023
4 | EX-32.1 | acrv-ex32_1.htm | EX-32.1 | 11412
5 | EX-32.2 | acrv-ex32_2.htm | EX-32.2 | 11395
| Complete submission text file | 0000950170-23-061553.txt |  | 9489691

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | acrv-20230930.xsd | EX-101.SCH | 56301
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | acrv-20230930_pre.xml | EX-101.PRE | 385631
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | acrv-20230930_cal.xml | EX-101.CAL | 52556
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | acrv-20230930_lab.xml | EX-101.LAB | 481898
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | acrv-20230930_def.xml | EX-101.DEF | 249575
63 | EXTRACTED XBRL INSTANCE DOCUMENT | acrv-20230930_htm.xml | XML | 1616911

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41551 | Film No.: 231390149
SIC: 2834 Pharmaceutical Preparations